Arrowhead Pharmaceuticals Inc.

ARWR | NASDAQ

Price Alert Chart Builder DCF Calculator

$68.79

+$2.31 (+3.47%)

At close: Sep 21, 2026, 4:00 PM ET

$66.69

-$2.10 (-3.05%)

Pre-market: Sep 22, 2026, 8:46 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Net Income	30.11M	-609.69M	-209.28M	-176.49M	-140.85M	-84.55M
Depreciation & Amortization	23.93M	18.6M	12.49M	10.42M	8.27M	5.94M
Stock-Based Compensation	63.37M	73.97M	78.13M	120.89M	76.67M	43.38M
Other Working Capital	32.45M	30.63M	-85.96M	-100.55M	235.44M	-60.07M
Other Non-Cash Items	80.38M	29.19M	16.31M	7.34M	-1.44M	505K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-18.24M	25.09M	-51.55M	-98.29M	228.66M	-61.08M
Operating Cash Flow	179.55M	-462.85M	-153.89M	-136.13M	171.31M	-95.8M
Capital Expenditures	-22.67M	-141.47M	-176.74M	-52.78M	-23.57M	-11.95M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-796.26M	-720.95M	-246.14M	-223.39M	-240.7M	-278.96M
Sales Maturities Of Investments	689.63M	442.34M	326.72M	270.75M	122.59M	50.14M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-129.29M	-420.07M	-96.16M	-5.42M	-141.68M	-240.78M
Debt Repayment	-191.37M	392M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-5M	46.87M	250M	60M	11.31M	7.47M
Financial Cash Flow	74.01M	870.52M	253.05M	65.19M	11.31M	257.95M
Net Cash Flow	123.86M	-8.21M	2.89M	-76.43M	40.85M	-78.22M
Free Cash Flow	156.89M	-604.32M	-330.63M	-188.91M	147.75M	-107.75M
Adj. Free Cash Flow	93.52M	-678.29M	-408.76M	-309.8M	71.07M	-151.14M
Maintenance CapEx	n/a	-141.47M	-176.74M	n/a	-2.5M	-11.95M
Growth CapEx	-22.67M	n/a	n/a	-52.78M	-21.07M	n/a
Owner Earnings	179.55M	-604.32M	-330.63M	-136.13M	168.81M	-107.75M